Evidence map›Paper›PMID 20215348›Full record

ArticleDevelopment (Cambridge, England)2010

The RNA-binding protein bicaudal C regulates polycystin 2 in the kidney by antagonizing miR-17 activity.

Uyen Tran, Lise Zakin, Axel Schweickert, Raman Agrawal, Remziye Döger, Martin Blum, E M De Robertis, Oliver Wessely

Open access · bronzeAbstract read
In one paragraph

Article in Development (Cambridge, England), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 145 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Toxics · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Uyen TranDepartment of Cell Biology & Anatomy, LSU Health Sciences Center, MEB 6A12, 1901 Perdido Street, New Orleans, LA 70112, USA.
Lise Zakin
Axel Schweickert
Raman Agrawal
Remziye Döger
Martin Blum
E M De Robertis
Oliver Wessely
Louisiana State University Health Sciences Center New Orleans · USUniversity of California, Los Angeles · USUniversity of Hohenheim · DE

Funding

The Role of Bicaudal-C in Polycystic Kidney DiseaseR01DK080745 · NIDDK · LSU HEALTH SCIENCES CENTER · PI WESSELY, OLIVER · 2009 to 2013
$1.7M
HOMEOBOXES IN XENOPUS DEVELOPMENTR01HD021502 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DE ROBERTIS, EDWARD M · 1986 to 2011
$1.6M
Xenopus Bicaudal-C a Model for Polycystic Kidney DiseaseR21DK070671 · NIDDK · LSU HEALTH SCIENCES CENTER · PI WESSELY, OLIVER · 2005 to 2007
$424k
MicroRNAs in Kidney DevelopmentR21DK077763 · NIDDK · LSU HEALTH SCIENCES CENTER · PI WESSELY, OLIVER · 2007 to 2009
$392k
Howard Hughes Medical InstituteNICHD NIH HHS R01 HD021502NIDDK NIH HHS 1R01DK080745-01A2NIDDK NIH HHS 5R21DK070671-03NIDDK NIH HHS 5R21DK077763-03NIDDK NIH HHS R01 DK080745NIDDK NIH HHS R21 DK070671NIDDK NIH HHS R21 DK077763
6 · The paper itself

Abstract

The RNA-binding protein Bicaudal C is an important regulator of embryonic development in C. elegans, Drosophila and Xenopus. In mouse, bicaudal C (Bicc1) mutants are characterized by the formation of fluid-filled cysts in the kidney and by expansion of epithelial ducts in liver and pancreas. This phenotype is reminiscent of human forms of polycystic kidney disease (PKD). Here, we now provide data that Bicc1 functions by modulating the expression of polycystin 2 (Pkd2), a member of the transient receptor potential (TRP) superfamily. Molecular analyses demonstrate that Bicc1 acts as a post-transcriptional regulator upstream of Pkd2. It regulates the stability of Pkd2 mRNA and its translation efficiency. Bicc1 antagonized the repressive activity of the miR-17 microRNA family on the 3'UTR of Pkd2 mRNA. This was substantiated in Xenopus, in which the pronephric defects of bicc1 knockdowns were rescued by reducing miR-17 activity. At the cellular level, Bicc1 protein is localized to cytoplasmic foci that are positive for the P-body markers GW182 and HEDLs. Based on these data, we propose that the kidney phenotype in Bicc1(-/-) mutant mice is caused by dysregulation of a microRNA-based translational control mechanism.

Indexed as

Amino Acid SequenceAnimalsCarrier ProteinsEpistasis, GeneticGene TargetingHumansKidneyMiceMice, KnockoutMicroRNAsMolecular Sequence DataPhenotypePolycystic Kidney DiseasesRecombinant Fusion ProteinsRNA-Binding ProteinsSequence AlignmentBicc1 protein, mouseBICC1 protein, XenopusCarrier ProteinsMicroRNAsMirn17 microRNA, mouseRecombinant Fusion ProteinsRNA-Binding ProteinsTRPP Cation ChannelsXenopus Proteins

Identifiers

PMID20215348
PMCPMC2835326
OpenAlexW2103690924

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.